Study to investigate the safety and efficacy of Alesion® Dry Syrup under the proper use in daily clinical practice in Japanese paediatric patients with allergic rhinitis, eczema/dermatitis, urticaria and pruritus
Study Type
OBSERVATIONAL
Enrollment
3,793
Dry Syrup
Incidence of adverse drug reactions
classified by Medical Dictionary for Regulatory Activities (MedDRA) terminology
Time frame: up to 3 years
Incidence of adverse drug reactions classified by patient's background/treatment factors
Time frame: up to 3 years
Overall assessment of efficacy by investigator on a 3-point scale
Time frame: At 12 weeks and 52 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.